These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 27370248)

  • 1. Peptide-drug conjugates as effective prodrug strategies for targeted delivery.
    Wang Y; Cheetham AG; Angacian G; Su H; Xie L; Cui H
    Adv Drug Deliv Rev; 2017 Feb; 110-111():112-126. PubMed ID: 27370248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-Assembling Peptide Nanofibrous Hydrogel as a Versatile Drug Delivery Platform.
    Yu Z; Xu Q; Dong C; Lee SS; Gao L; Li Y; D'Ortenzio M; Wu J
    Curr Pharm Des; 2015; 21(29):4342-54. PubMed ID: 26323419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
    Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
    Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in self-assembled peptides: Implications for targeted drug delivery and vaccine engineering.
    Eskandari S; Guerin T; Toth I; Stephenson RJ
    Adv Drug Deliv Rev; 2017 Feb; 110-111():169-187. PubMed ID: 27356149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prodrugs as self-assembled hydrogels: a new paradigm for biomaterials.
    Vemula PK; Wiradharma N; Ankrum JA; Miranda OR; John G; Karp JM
    Curr Opin Biotechnol; 2013 Dec; 24(6):1174-82. PubMed ID: 23465753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-assembling peptide-based delivery of therapeutics for myocardial infarction.
    French KM; Somasuntharam I; Davis ME
    Adv Drug Deliv Rev; 2016 Jan; 96():40-53. PubMed ID: 25959427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Delivery with Designed Peptide Assemblies.
    Sis MJ; Webber MJ
    Trends Pharmacol Sci; 2019 Oct; 40(10):747-762. PubMed ID: 31493931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational Design of Short Peptide-Based Hydrogels with MMP-2 Responsiveness for Controlled Anticancer Peptide Delivery.
    Chen C; Zhang Y; Hou Z; Cui X; Zhao Y; Xu H
    Biomacromolecules; 2017 Nov; 18(11):3563-3571. PubMed ID: 28828862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signed, Sealed, Delivered: Conjugate and Prodrug Strategies as Targeted Delivery Vectors for Antibiotics.
    Cheng AV; Wuest WM
    ACS Infect Dis; 2019 Jun; 5(6):816-828. PubMed ID: 30969100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular design and synthesis of self-assembling camptothecin drug amphiphiles.
    Cheetham AG; Lin YA; Lin R; Cui H
    Acta Pharmacol Sin; 2017 Jun; 38(6):874-884. PubMed ID: 28260797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iterative Design Reveals Molecular Domain Relationships in Supramolecular Peptide-Drug Conjugates.
    Sis MJ; Liu D; Allen I; Webber MJ
    Biomacromolecules; 2024 Jul; 25(7):4482-4491. PubMed ID: 38870408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembling prodrug nanotherapeutics for synergistic tumor targeted drug delivery.
    Wang Z; Chen J; Little N; Lu J
    Acta Biomater; 2020 Jul; 111():20-28. PubMed ID: 32454086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells.
    Kalimuthu K; Lubin BC; Bazylevich A; Gellerman G; Shpilberg O; Luboshits G; Firer MA
    J Nanobiotechnology; 2018 Mar; 16(1):34. PubMed ID: 29602308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-shaped Peptide Amphiphiles Self Assemble into Nanofiber Networks.
    Fisusi FA; Notman R; Granger LA; Malkinson JP; Schatzlein AG; Uchegbu IF
    Pharm Nanotechnol; 2017; 5(3):215-219. PubMed ID: 28847269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxime-Linked Peptide-Daunomycin Conjugates as Good Tools for Selection of Suitable Homing Devices in Targeted Tumor Therapy: An Overview.
    Mező G; Gomena J; Ranđelović I; Dókus EL; Kiss K; Pethő L; Schuster S; Vári B; Vári-Mező D; Lajkó E; Polgár L; Kőhidai L; Tóvári J; Szabó I
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
    Luo C; Sun J; Sun B; He Z
    Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prodrugs in combination with nanocarriers as a strategy for promoting antitumoral efficiency.
    Lin MH; Hung CF; Hsu CY; Lin ZC; Fang JY
    Future Med Chem; 2019 Aug; 11(16):2131-2150. PubMed ID: 31538520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The design of peptide-amphiphiles as functional ligands for liposomal anticancer drug and gene delivery.
    Kuang H; Ku SH; Kokkoli E
    Adv Drug Deliv Rev; 2017 Feb; 110-111():80-101. PubMed ID: 27539561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-immolative Linkers in Prodrugs and Antibody Drug Conjugates in Cancer Treatment.
    Edupuganti VVSR; Tyndall JDATDA; Gamble AB
    Recent Pat Anticancer Drug Discov; 2021; 16(4):479-497. PubMed ID: 33966624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prodrug strategy for enhancing drug delivery via skin.
    Fang JY; Leu YL
    Curr Drug Discov Technol; 2006 Sep; 3(3):211-24. PubMed ID: 17311566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.